Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00572455 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure.
A Phase 2 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 2
- Development phase
- 318
- Enrollment target
NCT00572455 is a Phase 2 study that has completed, run by Pfizer. The registered enrollment target is 318 participants.
The verdict
NCT00572455, a Phase 2 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 318 participants
- Enrollment target
Study Summary
To evaluate the safety and efficacy of PF-04217329.
Interventions
- DRUG PF-04217329 - Lowest Dose
- DRUG PF-04217329 - Low Dose
- DRUG PF-04217329 - Middle Dose
- DRUG PF-04217329 - High Middle Dose
- DRUG PF-04217329 - High Dose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 318 participants |
| Start Date | 2007-12-11 |
| Est. Completion | 2009-06-26 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00572455
The ClinicalTrials.gov registry entry for NCT00572455 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 318 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which PF-04217329 - Lowest Dose is the first listed.
NCT00572455 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00572455 about?
NCT00572455 is a clinical study titled "Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure.". To evaluate the safety and efficacy of PF-04217329.
What is the current status of trial NCT00572455?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 318 participants. The study started on 2007-12-11. Estimated completion is 2009-06-26.
What interventions are being tested in trial NCT00572455?
The interventions under investigation include: PF-04217329 - Lowest Dose (DRUG), PF-04217329 - Low Dose (DRUG), PF-04217329 - Middle Dose (DRUG), PF-04217329 - High Middle Dose (DRUG), PF-04217329 - High Dose (DRUG).
Who is sponsoring clinical trial NCT00572455?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.